Related posts
TSX rebounds, Wall Street choppyMild gains, Charlie Munger diesStocks, yields climb, oil flatThis summary was created by AI, based on 8 opinions in the last 12 months.
GE HealthCare Technologies Inc (GEHC-Q) has garnered mixed reviews from various experts in the field. While some analysts respect the company's integration of AI within their products, especially MRIs, others express skepticism due to the competitive nature of the medical devices sector and concerns over government spending affecting healthcare. Investors have differing opinions on whether GEHC provides reasonable growth opportunities, with some preferring other options like GEV. Despite the relatively low Price-to-Earnings ratio of 21x, sentiments indicate a bearish trend among analysts, although a few believe in its potential based on solid cash flow and management strategies implemented during the company's transformation under Larry Culp. The prevailing view suggests that while there are challenges, potential upsides could make GEHC an interesting investment in the evolving healthcare landscape.
Spun out from GE. He's been buying it this year and holds a large position. They reported a great beat in late July. Eventually, GEHC will decouple from the rest of healthcare which has been lagging. (Maybe Wall St is nervous about Washington taking shots at healthcare in the election year coming up.) Shares are down 12% this month, and this is a cheap, great opportunity.
This GE health spin-off's equipment will be in big demand next year when doctors conduct MRIs to measure plaque in the brain (to determine which patients get the new Alzheimer's drug). Huge demand. Why are shares down 12 points since their report. Makes no sense. He bought more shares to average down.
GE HealthCare Technologies Inc is a American stock, trading under the symbol GEHC-Q on the NASDAQ (GEHC). It is usually referred to as NASDAQ:GEHC or GEHC-Q
In the last year, 6 stock analysts published opinions about GEHC-Q. 5 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for GE HealthCare Technologies Inc.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
6 stock analysts on Stockchase covered GE HealthCare Technologies Inc In the last year. It is a trending stock that is worth watching.
On 2025-04-04, GE HealthCare Technologies Inc (GEHC-Q) stock closed at a price of $62.84.